Mira Pharmaceuticals, Common Stock Market Value
| MIRA Stock | 1.18 0.07 5.60% |
| Symbol | MIRA |
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MIRA Pharmaceuticals,. If investors know MIRA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MIRA Pharmaceuticals, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of MIRA Pharmaceuticals, is measured differently than its book value, which is the value of MIRA that is recorded on the company's balance sheet. Investors also form their own opinion of MIRA Pharmaceuticals,'s value that differs from its market value or its book value, called intrinsic value, which is MIRA Pharmaceuticals,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MIRA Pharmaceuticals,'s market value can be influenced by many factors that don't directly affect MIRA Pharmaceuticals,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MIRA Pharmaceuticals,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if MIRA Pharmaceuticals, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MIRA Pharmaceuticals,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
MIRA Pharmaceuticals, 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to MIRA Pharmaceuticals,'s stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of MIRA Pharmaceuticals,.
| 12/15/2024 |
| 03/15/2025 |
If you would invest 0.00 in MIRA Pharmaceuticals, on December 15, 2024 and sell it all today you would earn a total of 0.00 from holding MIRA Pharmaceuticals, Common or generate 0.0% return on investment in MIRA Pharmaceuticals, over 90 days. MIRA Pharmaceuticals, is related to or competes with Genuine Parts, Enersys, Titan Machinery, Cosan SA, Centessa Pharmaceuticals, Coupang LLC, and Sea. More
MIRA Pharmaceuticals, Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure MIRA Pharmaceuticals,'s stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess MIRA Pharmaceuticals, Common upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.25 | |||
| Information Ratio | 0.064 | |||
| Maximum Drawdown | 28.99 | |||
| Value At Risk | (5.60) | |||
| Potential Upside | 9.57 |
MIRA Pharmaceuticals, Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for MIRA Pharmaceuticals,'s investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as MIRA Pharmaceuticals,'s standard deviation. In reality, there are many statistical measures that can use MIRA Pharmaceuticals, historical prices to predict the future MIRA Pharmaceuticals,'s volatility.| Risk Adjusted Performance | 0.0495 | |||
| Jensen Alpha | 0.3058 | |||
| Total Risk Alpha | 1.0 | |||
| Sortino Ratio | 0.0882 | |||
| Treynor Ratio | 0.734 |
MIRA Pharmaceuticals, Backtested Returns
MIRA Pharmaceuticals, appears to be extremely dangerous, given 3 months investment horizon. MIRA Pharmaceuticals, has Sharpe Ratio of 0.0467, which conveys that the firm had a 0.0467 % return per unit of volatility over the last 3 months. We have found twenty-nine technical indicators for MIRA Pharmaceuticals,, which you can use to evaluate the volatility of the firm. Please exercise MIRA Pharmaceuticals,'s risk adjusted performance of 0.0495, and Mean Deviation of 3.94 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, MIRA Pharmaceuticals, holds a performance score of 3. The company secures a Beta (Market Risk) of 0.36, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, MIRA Pharmaceuticals,'s returns are expected to increase less than the market. However, during the bear market, the loss of holding MIRA Pharmaceuticals, is expected to be smaller as well. Please check MIRA Pharmaceuticals,'s expected short fall, day median price, and the relationship between the potential upside and accumulation distribution , to make a quick decision on whether MIRA Pharmaceuticals,'s current price movements will revert.
Auto-correlation | -0.13 |
Insignificant reverse predictability
MIRA Pharmaceuticals, Common has insignificant reverse predictability. Overlapping area represents the amount of predictability between MIRA Pharmaceuticals, time series from 15th of December 2024 to 29th of January 2025 and 29th of January 2025 to 15th of March 2025. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of MIRA Pharmaceuticals, price movement. The serial correlation of -0.13 indicates that less than 13.0% of current MIRA Pharmaceuticals, price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.13 | |
| Spearman Rank Test | -0.48 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
MIRA Pharmaceuticals, lagged returns against current returns
Autocorrelation, which is MIRA Pharmaceuticals, stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting MIRA Pharmaceuticals,'s stock expected returns. We can calculate the autocorrelation of MIRA Pharmaceuticals, returns to help us make a trade decision. For example, suppose you find that MIRA Pharmaceuticals, has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
MIRA Pharmaceuticals, regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If MIRA Pharmaceuticals, stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if MIRA Pharmaceuticals, stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in MIRA Pharmaceuticals, stock over time.
Current vs Lagged Prices |
| Timeline |
MIRA Pharmaceuticals, Lagged Returns
When evaluating MIRA Pharmaceuticals,'s market value, investors can use the concept of autocorrelation to see how much of an impact past prices of MIRA Pharmaceuticals, stock have on its future price. MIRA Pharmaceuticals, autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, MIRA Pharmaceuticals, autocorrelation shows the relationship between MIRA Pharmaceuticals, stock current value and its past values and can show if there is a momentum factor associated with investing in MIRA Pharmaceuticals, Common.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether MIRA Pharmaceuticals, offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of MIRA Pharmaceuticals,'s financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mira Pharmaceuticals, Common Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mira Pharmaceuticals, Common Stock:Check out MIRA Pharmaceuticals, Correlation, MIRA Pharmaceuticals, Volatility and MIRA Pharmaceuticals, Alpha and Beta module to complement your research on MIRA Pharmaceuticals,. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
MIRA Pharmaceuticals, technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.